Medical Care
Global Cachexia Treatment Market Research Report 2025
- Jul 08, 25
- ID: 347524
- Pages: 84
- Figures: 90
- Views: 2
The global market for Cachexia Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cachexia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cachexia Treatment.
The Cachexia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cachexia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cachexia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alder Biopharmaceuticals Inc.
GTx Inc.
Helsinn Group
Merck & Co. Inc.
Bristol-Myers Squibb Company
Helsinn Healthcare S.A.
PsiOxus
Purdue Pharma L.P.
Eterna Zentaris Inc.
Aphios Corporation
Neurim
Novartis AG
SkyePharma
Segment by Type
Weight Loss Stabilizers
Appetite Stimulants
Progestogens
Corticosteroids
Combination therapies
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cachexia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cachexia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cachexia Treatment.
The Cachexia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cachexia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cachexia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alder Biopharmaceuticals Inc.
GTx Inc.
Helsinn Group
Merck & Co. Inc.
Bristol-Myers Squibb Company
Helsinn Healthcare S.A.
PsiOxus
Purdue Pharma L.P.
Eterna Zentaris Inc.
Aphios Corporation
Neurim
Novartis AG
SkyePharma
Segment by Type
Weight Loss Stabilizers
Appetite Stimulants
Progestogens
Corticosteroids
Combination therapies
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cachexia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cachexia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Weight Loss Stabilizers
1.2.3 Appetite Stimulants
1.2.4 Progestogens
1.2.5 Corticosteroids
1.2.6 Combination therapies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cachexia Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cachexia Treatment Market Perspective (2020-2031)
2.2 Global Cachexia Treatment Growth Trends by Region
2.2.1 Global Cachexia Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cachexia Treatment Historic Market Size by Region (2020-2025)
2.2.3 Cachexia Treatment Forecasted Market Size by Region (2026-2031)
2.3 Cachexia Treatment Market Dynamics
2.3.1 Cachexia Treatment Industry Trends
2.3.2 Cachexia Treatment Market Drivers
2.3.3 Cachexia Treatment Market Challenges
2.3.4 Cachexia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cachexia Treatment Players by Revenue
3.1.1 Global Top Cachexia Treatment Players by Revenue (2020-2025)
3.1.2 Global Cachexia Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cachexia Treatment Revenue
3.4 Global Cachexia Treatment Market Concentration Ratio
3.4.1 Global Cachexia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cachexia Treatment Revenue in 2024
3.5 Global Key Players of Cachexia Treatment Head office and Area Served
3.6 Global Key Players of Cachexia Treatment, Product and Application
3.7 Global Key Players of Cachexia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cachexia Treatment Breakdown Data by Type
4.1 Global Cachexia Treatment Historic Market Size by Type (2020-2025)
4.2 Global Cachexia Treatment Forecasted Market Size by Type (2026-2031)
5 Cachexia Treatment Breakdown Data by Application
5.1 Global Cachexia Treatment Historic Market Size by Application (2020-2025)
5.2 Global Cachexia Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cachexia Treatment Market Size (2020-2031)
6.2 North America Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cachexia Treatment Market Size by Country (2020-2025)
6.4 North America Cachexia Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cachexia Treatment Market Size (2020-2031)
7.2 Europe Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cachexia Treatment Market Size by Country (2020-2025)
7.4 Europe Cachexia Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cachexia Treatment Market Size (2020-2031)
8.2 Asia-Pacific Cachexia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cachexia Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Cachexia Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cachexia Treatment Market Size (2020-2031)
9.2 Latin America Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cachexia Treatment Market Size by Country (2020-2025)
9.4 Latin America Cachexia Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cachexia Treatment Market Size (2020-2031)
10.2 Middle East & Africa Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cachexia Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Cachexia Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alder Biopharmaceuticals Inc.
11.1.1 Alder Biopharmaceuticals Inc. Company Details
11.1.2 Alder Biopharmaceuticals Inc. Business Overview
11.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Introduction
11.1.4 Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.1.5 Alder Biopharmaceuticals Inc. Recent Development
11.2 GTx Inc.
11.2.1 GTx Inc. Company Details
11.2.2 GTx Inc. Business Overview
11.2.3 GTx Inc. Cachexia Treatment Introduction
11.2.4 GTx Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.2.5 GTx Inc. Recent Development
11.3 Helsinn Group
11.3.1 Helsinn Group Company Details
11.3.2 Helsinn Group Business Overview
11.3.3 Helsinn Group Cachexia Treatment Introduction
11.3.4 Helsinn Group Revenue in Cachexia Treatment Business (2020-2025)
11.3.5 Helsinn Group Recent Development
11.4 Merck & Co. Inc.
11.4.1 Merck & Co. Inc. Company Details
11.4.2 Merck & Co. Inc. Business Overview
11.4.3 Merck & Co. Inc. Cachexia Treatment Introduction
11.4.4 Merck & Co. Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.4.5 Merck & Co. Inc. Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Cachexia Treatment Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2020-2025)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Helsinn Healthcare S.A.
11.6.1 Helsinn Healthcare S.A. Company Details
11.6.2 Helsinn Healthcare S.A. Business Overview
11.6.3 Helsinn Healthcare S.A. Cachexia Treatment Introduction
11.6.4 Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2020-2025)
11.6.5 Helsinn Healthcare S.A. Recent Development
11.7 PsiOxus
11.7.1 PsiOxus Company Details
11.7.2 PsiOxus Business Overview
11.7.3 PsiOxus Cachexia Treatment Introduction
11.7.4 PsiOxus Revenue in Cachexia Treatment Business (2020-2025)
11.7.5 PsiOxus Recent Development
11.8 Purdue Pharma L.P.
11.8.1 Purdue Pharma L.P. Company Details
11.8.2 Purdue Pharma L.P. Business Overview
11.8.3 Purdue Pharma L.P. Cachexia Treatment Introduction
11.8.4 Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2020-2025)
11.8.5 Purdue Pharma L.P. Recent Development
11.9 Eterna Zentaris Inc.
11.9.1 Eterna Zentaris Inc. Company Details
11.9.2 Eterna Zentaris Inc. Business Overview
11.9.3 Eterna Zentaris Inc. Cachexia Treatment Introduction
11.9.4 Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.9.5 Eterna Zentaris Inc. Recent Development
11.10 Aphios Corporation
11.10.1 Aphios Corporation Company Details
11.10.2 Aphios Corporation Business Overview
11.10.3 Aphios Corporation Cachexia Treatment Introduction
11.10.4 Aphios Corporation Revenue in Cachexia Treatment Business (2020-2025)
11.10.5 Aphios Corporation Recent Development
11.11 Neurim
11.11.1 Neurim Company Details
11.11.2 Neurim Business Overview
11.11.3 Neurim Cachexia Treatment Introduction
11.11.4 Neurim Revenue in Cachexia Treatment Business (2020-2025)
11.11.5 Neurim Recent Development
11.12 Novartis AG
11.12.1 Novartis AG Company Details
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Cachexia Treatment Introduction
11.12.4 Novartis AG Revenue in Cachexia Treatment Business (2020-2025)
11.12.5 Novartis AG Recent Development
11.13 SkyePharma
11.13.1 SkyePharma Company Details
11.13.2 SkyePharma Business Overview
11.13.3 SkyePharma Cachexia Treatment Introduction
11.13.4 SkyePharma Revenue in Cachexia Treatment Business (2020-2025)
11.13.5 SkyePharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cachexia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Weight Loss Stabilizers
1.2.3 Appetite Stimulants
1.2.4 Progestogens
1.2.5 Corticosteroids
1.2.6 Combination therapies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cachexia Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cachexia Treatment Market Perspective (2020-2031)
2.2 Global Cachexia Treatment Growth Trends by Region
2.2.1 Global Cachexia Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cachexia Treatment Historic Market Size by Region (2020-2025)
2.2.3 Cachexia Treatment Forecasted Market Size by Region (2026-2031)
2.3 Cachexia Treatment Market Dynamics
2.3.1 Cachexia Treatment Industry Trends
2.3.2 Cachexia Treatment Market Drivers
2.3.3 Cachexia Treatment Market Challenges
2.3.4 Cachexia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cachexia Treatment Players by Revenue
3.1.1 Global Top Cachexia Treatment Players by Revenue (2020-2025)
3.1.2 Global Cachexia Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cachexia Treatment Revenue
3.4 Global Cachexia Treatment Market Concentration Ratio
3.4.1 Global Cachexia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cachexia Treatment Revenue in 2024
3.5 Global Key Players of Cachexia Treatment Head office and Area Served
3.6 Global Key Players of Cachexia Treatment, Product and Application
3.7 Global Key Players of Cachexia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cachexia Treatment Breakdown Data by Type
4.1 Global Cachexia Treatment Historic Market Size by Type (2020-2025)
4.2 Global Cachexia Treatment Forecasted Market Size by Type (2026-2031)
5 Cachexia Treatment Breakdown Data by Application
5.1 Global Cachexia Treatment Historic Market Size by Application (2020-2025)
5.2 Global Cachexia Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cachexia Treatment Market Size (2020-2031)
6.2 North America Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cachexia Treatment Market Size by Country (2020-2025)
6.4 North America Cachexia Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cachexia Treatment Market Size (2020-2031)
7.2 Europe Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cachexia Treatment Market Size by Country (2020-2025)
7.4 Europe Cachexia Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cachexia Treatment Market Size (2020-2031)
8.2 Asia-Pacific Cachexia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cachexia Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Cachexia Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cachexia Treatment Market Size (2020-2031)
9.2 Latin America Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cachexia Treatment Market Size by Country (2020-2025)
9.4 Latin America Cachexia Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cachexia Treatment Market Size (2020-2031)
10.2 Middle East & Africa Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cachexia Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Cachexia Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alder Biopharmaceuticals Inc.
11.1.1 Alder Biopharmaceuticals Inc. Company Details
11.1.2 Alder Biopharmaceuticals Inc. Business Overview
11.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Introduction
11.1.4 Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.1.5 Alder Biopharmaceuticals Inc. Recent Development
11.2 GTx Inc.
11.2.1 GTx Inc. Company Details
11.2.2 GTx Inc. Business Overview
11.2.3 GTx Inc. Cachexia Treatment Introduction
11.2.4 GTx Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.2.5 GTx Inc. Recent Development
11.3 Helsinn Group
11.3.1 Helsinn Group Company Details
11.3.2 Helsinn Group Business Overview
11.3.3 Helsinn Group Cachexia Treatment Introduction
11.3.4 Helsinn Group Revenue in Cachexia Treatment Business (2020-2025)
11.3.5 Helsinn Group Recent Development
11.4 Merck & Co. Inc.
11.4.1 Merck & Co. Inc. Company Details
11.4.2 Merck & Co. Inc. Business Overview
11.4.3 Merck & Co. Inc. Cachexia Treatment Introduction
11.4.4 Merck & Co. Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.4.5 Merck & Co. Inc. Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Cachexia Treatment Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2020-2025)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Helsinn Healthcare S.A.
11.6.1 Helsinn Healthcare S.A. Company Details
11.6.2 Helsinn Healthcare S.A. Business Overview
11.6.3 Helsinn Healthcare S.A. Cachexia Treatment Introduction
11.6.4 Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2020-2025)
11.6.5 Helsinn Healthcare S.A. Recent Development
11.7 PsiOxus
11.7.1 PsiOxus Company Details
11.7.2 PsiOxus Business Overview
11.7.3 PsiOxus Cachexia Treatment Introduction
11.7.4 PsiOxus Revenue in Cachexia Treatment Business (2020-2025)
11.7.5 PsiOxus Recent Development
11.8 Purdue Pharma L.P.
11.8.1 Purdue Pharma L.P. Company Details
11.8.2 Purdue Pharma L.P. Business Overview
11.8.3 Purdue Pharma L.P. Cachexia Treatment Introduction
11.8.4 Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2020-2025)
11.8.5 Purdue Pharma L.P. Recent Development
11.9 Eterna Zentaris Inc.
11.9.1 Eterna Zentaris Inc. Company Details
11.9.2 Eterna Zentaris Inc. Business Overview
11.9.3 Eterna Zentaris Inc. Cachexia Treatment Introduction
11.9.4 Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2020-2025)
11.9.5 Eterna Zentaris Inc. Recent Development
11.10 Aphios Corporation
11.10.1 Aphios Corporation Company Details
11.10.2 Aphios Corporation Business Overview
11.10.3 Aphios Corporation Cachexia Treatment Introduction
11.10.4 Aphios Corporation Revenue in Cachexia Treatment Business (2020-2025)
11.10.5 Aphios Corporation Recent Development
11.11 Neurim
11.11.1 Neurim Company Details
11.11.2 Neurim Business Overview
11.11.3 Neurim Cachexia Treatment Introduction
11.11.4 Neurim Revenue in Cachexia Treatment Business (2020-2025)
11.11.5 Neurim Recent Development
11.12 Novartis AG
11.12.1 Novartis AG Company Details
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Cachexia Treatment Introduction
11.12.4 Novartis AG Revenue in Cachexia Treatment Business (2020-2025)
11.12.5 Novartis AG Recent Development
11.13 SkyePharma
11.13.1 SkyePharma Company Details
11.13.2 SkyePharma Business Overview
11.13.3 SkyePharma Cachexia Treatment Introduction
11.13.4 SkyePharma Revenue in Cachexia Treatment Business (2020-2025)
11.13.5 SkyePharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cachexia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Weight Loss Stabilizers
Table 3. Key Players of Appetite Stimulants
Table 4. Key Players of Progestogens
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Combination therapies
Table 7. Key Players of Others
Table 8. Global Cachexia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cachexia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Cachexia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Cachexia Treatment Market Share by Region (2020-2025)
Table 12. Global Cachexia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Cachexia Treatment Market Share by Region (2026-2031)
Table 14. Cachexia Treatment Market Trends
Table 15. Cachexia Treatment Market Drivers
Table 16. Cachexia Treatment Market Challenges
Table 17. Cachexia Treatment Market Restraints
Table 18. Global Cachexia Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cachexia Treatment Market Share by Players (2020-2025)
Table 20. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2024)
Table 21. Ranking of Global Top Cachexia Treatment Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cachexia Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cachexia Treatment, Headquarters and Area Served
Table 24. Global Key Players of Cachexia Treatment, Product and Application
Table 25. Global Key Players of Cachexia Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cachexia Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Cachexia Treatment Revenue Market Share by Type (2020-2025)
Table 29. Global Cachexia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Cachexia Treatment Revenue Market Share by Type (2026-2031)
Table 31. Global Cachexia Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Cachexia Treatment Revenue Market Share by Application (2020-2025)
Table 33. Global Cachexia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Cachexia Treatment Revenue Market Share by Application (2026-2031)
Table 35. North America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Cachexia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Cachexia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Cachexia Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 50. Alder Biopharmaceuticals Inc. Company Details
Table 51. Alder Biopharmaceuticals Inc. Business Overview
Table 52. Alder Biopharmaceuticals Inc. Cachexia Treatment Product
Table 53. Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 54. Alder Biopharmaceuticals Inc. Recent Development
Table 55. GTx Inc. Company Details
Table 56. GTx Inc. Business Overview
Table 57. GTx Inc. Cachexia Treatment Product
Table 58. GTx Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 59. GTx Inc. Recent Development
Table 60. Helsinn Group Company Details
Table 61. Helsinn Group Business Overview
Table 62. Helsinn Group Cachexia Treatment Product
Table 63. Helsinn Group Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 64. Helsinn Group Recent Development
Table 65. Merck & Co. Inc. Company Details
Table 66. Merck & Co. Inc. Business Overview
Table 67. Merck & Co. Inc. Cachexia Treatment Product
Table 68. Merck & Co. Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 69. Merck & Co. Inc. Recent Development
Table 70. Bristol-Myers Squibb Company Company Details
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Cachexia Treatment Product
Table 73. Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. Helsinn Healthcare S.A. Company Details
Table 76. Helsinn Healthcare S.A. Business Overview
Table 77. Helsinn Healthcare S.A. Cachexia Treatment Product
Table 78. Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 79. Helsinn Healthcare S.A. Recent Development
Table 80. PsiOxus Company Details
Table 81. PsiOxus Business Overview
Table 82. PsiOxus Cachexia Treatment Product
Table 83. PsiOxus Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 84. PsiOxus Recent Development
Table 85. Purdue Pharma L.P. Company Details
Table 86. Purdue Pharma L.P. Business Overview
Table 87. Purdue Pharma L.P. Cachexia Treatment Product
Table 88. Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 89. Purdue Pharma L.P. Recent Development
Table 90. Eterna Zentaris Inc. Company Details
Table 91. Eterna Zentaris Inc. Business Overview
Table 92. Eterna Zentaris Inc. Cachexia Treatment Product
Table 93. Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 94. Eterna Zentaris Inc. Recent Development
Table 95. Aphios Corporation Company Details
Table 96. Aphios Corporation Business Overview
Table 97. Aphios Corporation Cachexia Treatment Product
Table 98. Aphios Corporation Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 99. Aphios Corporation Recent Development
Table 100. Neurim Company Details
Table 101. Neurim Business Overview
Table 102. Neurim Cachexia Treatment Product
Table 103. Neurim Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 104. Neurim Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Cachexia Treatment Product
Table 108. Novartis AG Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. SkyePharma Company Details
Table 111. SkyePharma Business Overview
Table 112. SkyePharma Cachexia Treatment Product
Table 113. SkyePharma Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 114. SkyePharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Cachexia Treatment Picture
Figure 2. Global Cachexia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cachexia Treatment Market Share by Type: 2024 VS 2031
Figure 4. Weight Loss Stabilizers Features
Figure 5. Appetite Stimulants Features
Figure 6. Progestogens Features
Figure 7. Corticosteroids Features
Figure 8. Combination therapies Features
Figure 9. Others Features
Figure 10. Global Cachexia Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Cachexia Treatment Market Share by Application: 2024 VS 2031
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Drug Stores Case Studies
Figure 15. Online Case Studies
Figure 16. Cachexia Treatment Report Years Considered
Figure 17. Global Cachexia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cachexia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cachexia Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Cachexia Treatment Market Share by Players in 2024
Figure 21. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cachexia Treatment Revenue in 2024
Figure 23. North America Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cachexia Treatment Market Share by Country (2020-2031)
Figure 25. United States Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cachexia Treatment Market Share by Country (2020-2031)
Figure 29. Germany Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cachexia Treatment Market Share by Region (2020-2031)
Figure 37. China Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cachexia Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cachexia Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Alder Biopharmaceuticals Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 53. GTx Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 54. Helsinn Group Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 55. Merck & Co. Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 57. Helsinn Healthcare S.A. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 58. PsiOxus Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 59. Purdue Pharma L.P. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 60. Eterna Zentaris Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 61. Aphios Corporation Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 62. Neurim Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 63. Novartis AG Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 64. SkyePharma Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Cachexia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Weight Loss Stabilizers
Table 3. Key Players of Appetite Stimulants
Table 4. Key Players of Progestogens
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Combination therapies
Table 7. Key Players of Others
Table 8. Global Cachexia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cachexia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Cachexia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Cachexia Treatment Market Share by Region (2020-2025)
Table 12. Global Cachexia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Cachexia Treatment Market Share by Region (2026-2031)
Table 14. Cachexia Treatment Market Trends
Table 15. Cachexia Treatment Market Drivers
Table 16. Cachexia Treatment Market Challenges
Table 17. Cachexia Treatment Market Restraints
Table 18. Global Cachexia Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cachexia Treatment Market Share by Players (2020-2025)
Table 20. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2024)
Table 21. Ranking of Global Top Cachexia Treatment Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cachexia Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cachexia Treatment, Headquarters and Area Served
Table 24. Global Key Players of Cachexia Treatment, Product and Application
Table 25. Global Key Players of Cachexia Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cachexia Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Cachexia Treatment Revenue Market Share by Type (2020-2025)
Table 29. Global Cachexia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Cachexia Treatment Revenue Market Share by Type (2026-2031)
Table 31. Global Cachexia Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Cachexia Treatment Revenue Market Share by Application (2020-2025)
Table 33. Global Cachexia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Cachexia Treatment Revenue Market Share by Application (2026-2031)
Table 35. North America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Cachexia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Cachexia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Cachexia Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 50. Alder Biopharmaceuticals Inc. Company Details
Table 51. Alder Biopharmaceuticals Inc. Business Overview
Table 52. Alder Biopharmaceuticals Inc. Cachexia Treatment Product
Table 53. Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 54. Alder Biopharmaceuticals Inc. Recent Development
Table 55. GTx Inc. Company Details
Table 56. GTx Inc. Business Overview
Table 57. GTx Inc. Cachexia Treatment Product
Table 58. GTx Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 59. GTx Inc. Recent Development
Table 60. Helsinn Group Company Details
Table 61. Helsinn Group Business Overview
Table 62. Helsinn Group Cachexia Treatment Product
Table 63. Helsinn Group Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 64. Helsinn Group Recent Development
Table 65. Merck & Co. Inc. Company Details
Table 66. Merck & Co. Inc. Business Overview
Table 67. Merck & Co. Inc. Cachexia Treatment Product
Table 68. Merck & Co. Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 69. Merck & Co. Inc. Recent Development
Table 70. Bristol-Myers Squibb Company Company Details
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Cachexia Treatment Product
Table 73. Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. Helsinn Healthcare S.A. Company Details
Table 76. Helsinn Healthcare S.A. Business Overview
Table 77. Helsinn Healthcare S.A. Cachexia Treatment Product
Table 78. Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 79. Helsinn Healthcare S.A. Recent Development
Table 80. PsiOxus Company Details
Table 81. PsiOxus Business Overview
Table 82. PsiOxus Cachexia Treatment Product
Table 83. PsiOxus Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 84. PsiOxus Recent Development
Table 85. Purdue Pharma L.P. Company Details
Table 86. Purdue Pharma L.P. Business Overview
Table 87. Purdue Pharma L.P. Cachexia Treatment Product
Table 88. Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 89. Purdue Pharma L.P. Recent Development
Table 90. Eterna Zentaris Inc. Company Details
Table 91. Eterna Zentaris Inc. Business Overview
Table 92. Eterna Zentaris Inc. Cachexia Treatment Product
Table 93. Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 94. Eterna Zentaris Inc. Recent Development
Table 95. Aphios Corporation Company Details
Table 96. Aphios Corporation Business Overview
Table 97. Aphios Corporation Cachexia Treatment Product
Table 98. Aphios Corporation Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 99. Aphios Corporation Recent Development
Table 100. Neurim Company Details
Table 101. Neurim Business Overview
Table 102. Neurim Cachexia Treatment Product
Table 103. Neurim Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 104. Neurim Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Cachexia Treatment Product
Table 108. Novartis AG Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. SkyePharma Company Details
Table 111. SkyePharma Business Overview
Table 112. SkyePharma Cachexia Treatment Product
Table 113. SkyePharma Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)
Table 114. SkyePharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Cachexia Treatment Picture
Figure 2. Global Cachexia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cachexia Treatment Market Share by Type: 2024 VS 2031
Figure 4. Weight Loss Stabilizers Features
Figure 5. Appetite Stimulants Features
Figure 6. Progestogens Features
Figure 7. Corticosteroids Features
Figure 8. Combination therapies Features
Figure 9. Others Features
Figure 10. Global Cachexia Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Cachexia Treatment Market Share by Application: 2024 VS 2031
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Drug Stores Case Studies
Figure 15. Online Case Studies
Figure 16. Cachexia Treatment Report Years Considered
Figure 17. Global Cachexia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cachexia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cachexia Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Cachexia Treatment Market Share by Players in 2024
Figure 21. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cachexia Treatment Revenue in 2024
Figure 23. North America Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cachexia Treatment Market Share by Country (2020-2031)
Figure 25. United States Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cachexia Treatment Market Share by Country (2020-2031)
Figure 29. Germany Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cachexia Treatment Market Share by Region (2020-2031)
Figure 37. China Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cachexia Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cachexia Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Alder Biopharmaceuticals Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 53. GTx Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 54. Helsinn Group Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 55. Merck & Co. Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 57. Helsinn Healthcare S.A. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 58. PsiOxus Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 59. Purdue Pharma L.P. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 60. Eterna Zentaris Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 61. Aphios Corporation Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 62. Neurim Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 63. Novartis AG Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 64. SkyePharma Revenue Growth Rate in Cachexia Treatment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232